top of page
Rachael Headshot updated background.jpg



Rachael A. Ream, J.D., Ph.D. has represented hospitals, physician groups, pharmacies, and other health care clients in strategic transactions, such as mergers and acquisitions, private equity transactions, joint ventures and physician contracting matters, including co-management arrangements, physician recruitment agreements, and employment and medical director agreements.  Ms. Ream regularly assists clients with Medicaid audits, pharmacy audits, and responding to Statements of Deficiency.  She also drafts and negotiates strategic supply management and equipment leasing and purchase agreements.


Ms. Ream represents clients on compliance matters, including defense of Medicare and Medicaid fraud and abuse cases, EMTALA, audits.  She also advises clients regarding Anti-Kickback Statute and Stark Law compliance and HIPAA and HITECH compliance.  She has experience conducting compliance risk assessments and GAP analyses, drafting compliance policies and procedures, and conducting compliance training.


Ms. Ream has extensive background in academic research and has represented clients in the area of research law, including negotiating Material Transfer Agreements, IRB Agreements, Clinical Trial Agreements, and the Common Rule. She earned a Ph.D. in Biological Sciences from Stanford University and completed a post-doctoral research fellowship in Biochemistry at Stanford University School of Medicine.  Prior to graduating from Case Western Reserve University School of Law, Ms. Ream worked as a medical writer and editor in clinical research and helped clients prepare for FDA advisory panels.


Bachelor of Science, University of Toledo, cum laude, 1996

Doctor of Philosophy, Stanford University, 2002

Juris Doctor, Case Western Reserve University School of Law, magna cum laude, 2008


Bar of Ohio

Bar of Oregon

Bar of Washington


American Health Lawyers Association

American Society of Pharmacy Law

Washington State Bar Association

Washington State Society of Healthcare Attorneys


Order of the Coif

Case Western Reserve University Law Review – Publisher


Washington State Attorney General Opinion Upholds Collaborative Drug Therapy Agreements between Prescribers and Pharmacists,” Studebaker Nault Legal Alert, February 3, 2021 


Medicare Telehealth and the COVID-19 Public Health Emergency,” Studebaker Nault Legal Alert, December 22, 2020

Oregon Governor Requires Cancellation and Rescheduling of Elective and Non-Urgent Medical Procedures in Response to COVID-19,” Studebaker Nault Legal Alert, March 26, 2020​

“State Response to Opioid Crisis and Opioid Prescribing Requirements: A 50 State Survey”, contributor to Oregon section, American Health Lawyers Association, November 6, 2019 


“Emergency Medical and Labor Treatment Act (EMTALA) Enforcement,” Oregon Association of Hospitals and Health Systems Compliance Committee, November 12, 2019

“Evaluation of Corporate Compliance Programs,” Oregon Association of Hospitals and Health Systems Compliance Committee, July 9, 2019

“ASC Models: A Comparison of Management Service Organization and Private Equity Investments,” Pacific Northwest ASC Symposium, May 24, 2019

“Demystifying Buprenorphine Opiate Addiction Treatment,” American Society of Pharmacy Law Fall Meeting, November 2, 2018

 ​ ​

“Revisiting Charity Care and Beneficiary Inducements in the Light of New Guidance,” Oregon Rural Health Conference, October 5, 2018

“The Puzzle of Pharmacists as Providers: Fitting the Pieces Together to Cover Rural Communities,” Oregon Rural Health Conference, October 4, 2018 


“ASCs: The Role of Private Equity,” Pacific Northwest ASC Symposium, July 26, 2018

Oregon Office:

503.468.5995, Ext. 103

bottom of page